{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:40:16Z","timestamp":1777473616004,"version":"3.51.4"},"reference-count":16,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,28]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. The American Society of Hematology Research Collaborative (ASH RC) has built an SCD Data Hub (DH) to facilitate research and quality improvement using real-world data. To our knowledge, we report here the first analyses from the DH, focusing on cohort demographics and accurate identification of SCD diagnosis type. DH sites have data use agreements with ASH RC to extract and transfer electronic health record (EHR) data at least quarterly. Principal investigators (PI) provided additional attestation of SCD diagnosis based on existing local data sources deemed sufficient by the PI. A random sample of 25 patients (per site) with a physician-attested diagnosis and at least 1 encounter in 2022 had SCD type and other variables manually abstracted by site personnel. Concordance was calculated as the percentage of cases with the same SCD type determined by the physician-attested and abstracted methods. Twenty DH sites have submitted data for 23\u2009970 unique individuals with SCD. The median patient age was 23 years (range, birth to 75 years); 55.4% were female. Physician-attested SCD diagnosis types on 9484 patients from 13 sites were reported as HbSS (67.2%), HbSC (22.2%), HbS\u00df0thalassemia (2.1%), HbS\u03b2+thalassemia (6.1%), and HbS\/other (2.4%). Physician-attested SCD type had 94% (233\/248) concordance with manual chart abstraction. High concordance increases confidence in the validity of SCD DH data. Well-curated and transformed data on a large cohort of individuals with SCD will be leveraged to conduct observational studies and inform the design and feasibility of prospective interventional studies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025017562","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T21:50:02Z","timestamp":1769032202000},"page":"2608-2615","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["High concordance of physician-attestation with manual data abstraction for sickle cell type: an ASH RC Data Hub study"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4961-8103","authenticated-orcid":false,"given":"Alexis A.","family":"Thompson","sequence":"first","affiliation":[{"name":"1Division of Hematology, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1270-8132","authenticated-orcid":false,"given":"Ashima","family":"Singh","sequence":"additional","affiliation":[{"name":"2Division of Hematology and Oncology, Department of Pediatrics, Medical College of Wisconsin, Pewaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna S.","family":"Neuberg","sequence":"additional","affiliation":[{"name":"3Department of Data Science, Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Brandow","sequence":"additional","affiliation":[{"name":"4Department of Pediatrics, Section of Hematology\/Oncology\/Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-6176","authenticated-orcid":false,"given":"Allison A.","family":"King","sequence":"additional","affiliation":[{"name":"5School of Medicine, Washington University, Clayton, MO"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Lanzkron","sequence":"additional","affiliation":[{"name":"6Division of Hematology, Cardeza Foundation for Hematologic Research, Thomas Jefferson University, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Semmel","sequence":"additional","affiliation":[{"name":"7ASH Research Collaborative, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8853-3084","authenticated-orcid":false,"given":"Sam","family":"Walters","sequence":"additional","affiliation":[{"name":"7ASH Research Collaborative, Washington, DC"},{"name":"8Breakthrough Healthcare, Baltimore, MD"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Rogers","sequence":"additional","affiliation":[{"name":"7ASH Research Collaborative, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Torres","sequence":"additional","affiliation":[{"name":"7ASH Research Collaborative, Washington, DC"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Wood","sequence":"additional","affiliation":[{"name":"9Division of Hematology, Department of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"4 suppl","key":"2026042809470994200_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"6","key":"2026042809470994200_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1177\/0033354919881438","article-title":"Reducing health care disparities in sickle cell disease: a review","volume":"134","author":"Lee","year":"2019","journal-title":"Public Health Rep"},{"issue":"9757","key":"2026042809470994200_bib3","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","article-title":"Sickle-cell disease","volume":"376","author":"Rees","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"2026042809470994200_bib4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/bloodadvances.2018017541","article-title":"Identification of patients with hemoglobin SS\/Sbeta(0) thalassemia disease and pain crises within electronic health records","volume":"2","author":"Singh","year":"2018","journal-title":"Blood Adv"},{"key":"2026042809470994200_bib5","doi-asserted-by":"crossref","first-page":"e42816","DOI":"10.2196\/42816","article-title":"Evaluating the discriminatory ability of the Sickle Cell Data Collection Program's administrative claims case definition in identifying adults with sickle cell disease: validation study","volume":"9","author":"Singh","year":"2023","journal-title":"JMIR Public Health Surveill"},{"issue":"12","key":"2026042809470994200_bib6","doi-asserted-by":"crossref","first-page":"e28703","DOI":"10.1002\/pbc.28703","article-title":"Administrative data identify sickle cell disease: a critical review of approaches in U.S. health services research","volume":"67","author":"Grosse","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"2026042809470994200_bib7","doi-asserted-by":"crossref","first-page":"ooad036","DOI":"10.1093\/jamiaopen\/ooad036","article-title":"Common data model for sickle cell disease surveillance: considerations and implications","volume":"6","author":"Smeltzer","year":"2023","journal-title":"JAMIA Open"},{"issue":"23","key":"2026042809470994200_bib8","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1182\/bloodadvances.2021005902","article-title":"ASH Research Collaborative: a real-world data infrastructure to support real-world evidence development and learning healthcare systems in hematology","volume":"5","author":"Wood","year":"2021","journal-title":"Blood Adv"},{"issue":"3","key":"2026042809470994200_bib9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/jamiaopen\/ooaa037","article-title":"Opportunities for the use of health information technology to support research","volume":"3","author":"Zayas-Caban","year":"2020","journal-title":"JAMIA Open"},{"issue":"3","key":"2026042809470994200_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.acap.2016.12.005","article-title":"Identification and validation of a sickle cell disease cohort within electronic health records","volume":"17","author":"Michalik","year":"2017","journal-title":"Acad Pediatr"},{"issue":"5 suppl","key":"2026042809470994200_bib11","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1016\/j.acap.2014.02.008","article-title":"Identifying sickle cell disease cases using administrative claims","volume":"14","author":"Reeves","year":"2014","journal-title":"Acad Pediatr"},{"issue":"12","key":"2026042809470994200_bib12","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/pbc.25208","article-title":"Population based surveillance in sickle cell disease: methods, findings and implications from the California Registry and Surveillance System in Hemoglobinopathies project (RuSH)","volume":"61","author":"Paulukonis","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"9","key":"2026042809470994200_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7109a1","article-title":"Surveillance for sickle cell disease - Sickle Cell Data Collection Program, two states, 2004-2018","volume":"71","author":"Snyder","year":"2022","journal-title":"MMWR Surveill Summ"},{"issue":"4","key":"2026042809470994200_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.29245\/2572-9411\/2017\/4.1124","article-title":"The accuracy of hospital ICD-9-CM codes for determining sickle cell disease genotype","volume":"2","author":"Snyder","year":"2017","journal-title":"J Rare Dis Res Treat"},{"issue":"4","key":"2026042809470994200_bib15","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1093\/jamia\/ocaa008","article-title":"National health information technology priorities for research: a policy and development agenda","volume":"27","author":"Zayas-Caban","year":"2020","journal-title":"J Am Med Inform Assoc"},{"issue":"6","key":"2026042809470994200_bib16","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/jamia\/ocab032","article-title":"Meeting the challenge: health information technology's essential role in achieving precision medicine","volume":"28","author":"Zayas-Caban","year":"2021","journal-title":"J Am Med Inform Assoc"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2608\/2513787\/blooda_adv-2025-017562-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/8\/2608\/2513787\/blooda_adv-2025-017562-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:47:18Z","timestamp":1777384038000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/8\/2608\/566164\/High-concordance-of-physician-attestation-with"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4,28]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025017562","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,28]]},"published":{"date-parts":[[2026,4,15]]}}}